Amira Pharmaceuticals Receives Over $6 Million For Inflammatory Diseases
11/28/2005 – After Merck & Co. closed the doors of its San Diego facility earlier this year, venture investors and former employees banded together to form Amira Pharmaceuticals Inc., a biopharmaceutical company targeting inflammatory disease that has raised over $6 million. [ full story ]